Literature DB >> 9299560

Up-regulation of UCP-2 gene expression by PPAR agonists in preadipose and adipose cells.

J Aubert1, O Champigny, P Saint-Marc, R Negrel, S Collins, D Ricquier, G Ailhaud.   

Abstract

UCP-2 is a member of the emerging family of UCP homologues. Upon high-fat feeding, UCP-2 mRNA levels are increased in epididymal fat pads of A/J mice, suggesting that the flux of fatty acids entering adipose tissue may regulate UCP-2 gene expression. Since fatty acids act as positive transcriptional regulators of lipid-related genes by means of peroxisome proliferator-activated receptors (PPARs), the regulation of UCP-2 gene expression by PPAR agonists (carbacyclin, alpha-bromopalmitate, BRL49653) has been examined in mouse preadipose and adipose cells in primary cultures or from clonal lines (Ob1771, 3T3-F442A, 1B8). In preadipose cells, carbacyclin and alpha-bromopalmitate are active and BRL49653 shows no effect, whereas all these ligands are active in adipose cells. The stimulatory effect of PPAR agonists is potentiated by RXR agonists in adipose cells. In contrast to the UCP-1 gene, norepinephrine as a cAMP-elevating agent does not enhance the expression of UCP-2 gene. Altogether, the data favor a predominant role of PPARdelta in preadipose cells and the involvement of PPARgamma2 in adipose cells in up-regulating UCP-2 gene expression. Thus, a potential link between fatty acid metabolism and thermogenesis may exist in PPAR-expressing tissues. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299560     DOI: 10.1006/bbrc.1997.7348

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

Review 1.  Hormonal regulation of physiological cell turnover and apoptosis.

Authors:  R D Medh; E B Thompson
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

Review 2.  Control of energy metabolism by iodothyronines.

Authors:  A Lanni; M Moreno; A Lombardi; P de Lange; F Goglia
Journal:  J Endocrinol Invest       Date:  2001-12       Impact factor: 4.256

Review 3.  UCP2, a mitochondrial protein regulated at multiple levels.

Authors:  Massimo Donadelli; Ilaria Dando; Claudia Fiorini; Marta Palmieri
Journal:  Cell Mol Life Sci       Date:  2013-06-27       Impact factor: 9.261

Review 4.  The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP.

Authors:  D Ricquier; F Bouillaud
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

5.  Uncoupling lipid metabolism from inflammation through fatty acid binding protein-dependent expression of UCP2.

Authors:  Hongliang Xu; Ann V Hertzel; Kaylee A Steen; Qigui Wang; Jill Suttles; David A Bernlohr
Journal:  Mol Cell Biol       Date:  2015-01-12       Impact factor: 4.272

6.  A novel intronic peroxisome proliferator-activated receptor gamma enhancer in the uncoupling protein (UCP) 3 gene as a regulator of both UCP2 and -3 expression in adipocytes.

Authors:  Anne Bugge; Majken Siersbaek; Maria S Madsen; Anita Göndör; Carole Rougier; Susanne Mandrup
Journal:  J Biol Chem       Date:  2010-04-01       Impact factor: 5.157

7.  Chronic and acute effects of thiazolidinediones BM13.1258 and BM15.2054 on rat skeletal muscle glucose metabolism.

Authors:  C Fürnsinn; B Brunmair; M Meyer; S Neschen; R Furtmüller; M Roden; H F Kühnle; P Nowotny; B Schneider; W Waldhäusl
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

8.  Mechanism of ubiquitous expression of mouse uncoupling protein 2 mRNA: control by cis-acting DNA element in 5'-flanking region.

Authors:  H Yoshitomi; K Yamazaki; I Tanaka
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

Review 9.  Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus.

Authors:  Antona J Wagstaff; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

10.  Abnormal nonshivering thermogenesis in mice with inherited defects of fatty acid oxidation.

Authors:  C Guerra; R A Koza; K Walsh; D M Kurtz; P A Wood; L P Kozak
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.